✦ LIBER ✦

P-320 Gefitinib therapy of advanced non small-cell lung cancer (NSCLC): A Markov model-based economic analysis

✍ Scribed by Chouaid, C.; Monnet, I.; Robinet, G.; Perol, M.; Fournel, P.; Vergnenegre, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-455 A pilot study of sequential therap

✍ Bhutani, M.; Pathak, A.; Guleria, R.; Mohan, A.; Kochupillai, V. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

PCN34 COST-EFFECTIVENESS OF GEFITINIB FO

✍ PH Liu; FC Hu; JD Wang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

A phase I trial of gefitinib and nimotuz

✍ Kim, Se Hyun; Shim, Hyo Sup; Cho, Jaeho; Jeong, Jae Heon; Kim, Sun Mi; Hong, Yun 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 275 KB

353 Combined chemoradiation therapy for

✍ Douillard, J.Y.; Bardet, E.; Le Groumellec, A.; Maury, B.; Bennouna, J.; Morel, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Efficacy and tolerability of gefitinib i

✍ Cappuzzo, F; Bartolini, S; Ceresoli, G L; Tamberi, S; Spreafico, A; Lombardo, L; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

P-975 The results of the treatment with

✍ Skrickova, J.; Tomiskova, M.; Svobodnik, A.; Kaplanova, J.; Kadlec, B.; Palkova, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB